130 - Updates in Treating Bacterial Infections

Rapid Fire Moderator(s)

• 

  Elizabeth Hirsch, PharmD (she/her/hers)

  Associate Professor
  University of Minnesota College of Pharmacy
  Minneapolis, MN, United States

Presentations:

• 12:20 PM - 12:25 PM US PT

  Carbapenemase Resistance Detection by Direct Xpert Carba-R Assay on Flagged Blood Cultures
  

  Rapid Fire Presenter: Akansha Didwania, MBBS (she/her/hers) – All India Institute of Medical Sciences

  Co-Author: Manasvini Bhatt, MBBS, MD – ALL INDIA INSTITUTE OF MEDICAL SCIENCES,NEW DELHI

  Co-Author: Parul Kodan, MBBS, MD – All India Institute of Medcial Sciences

  Co-Author: Binit Kumar Singh, PhD – All India Institute of Medical Sciences, New Delhi

  Co-Author: sowjanya perumalla, MBBS, MD – All India Institute of Medical Sciences

  Co-Author: Sarita Mohapatra, MD – All India Institute of Medical Sciences, New Delhi

  Co-Author: Naveet Wig, MD Medicine – All India Institute of Medical Sciences

  Co-Author: Manish Soneja, MD – All India Institute Of Medical Sciences
• 12:25 PM - 12:30 PM US PT

  Potential Impact of Targeted Sequencing on Central Line-associated Bloodstream Infection (CLABSI) at Stanford Health Care, 2015–2024
  

  Rapid Fire Presenter: Guillermo Rodriguez-Nava, MD – Stanford University School of Medicine

  Co-Author: Goar Egoryan, MD – Stanford University

  Co-Author: Kyle Fu, MHA – Stanford Health Care

  Co-Author: John Shepard, BA, MBA, MHA – Stanford University

  Co-Author: Karen McIntyre, RN, MSN – Stanford Healthcare

  Co-Author: Mindy M. Sampson, DO – Stanford University

  Co-Author: Jorge Salinas, MD – Stanford University
• 12:30 PM - 12:35 PM US PT

  Daptomycin-Susceptible vs. Daptomycin-Non-susceptible Enterococcus Bloodstream Infections: Rates and Predictors of Treatment Failure and Predictors of Daptomycin Resistance
  

  Co-Author: Kelsey Olion, Pharm.D. – VA St. Louis HCS

  Rapid Fire Presenter: Ryan P. Moenster, Pharm.D., FIDSA (he/him/his) – St. Louis College of Pharmacy at UHSP/VA St. Louis HCS

  Co-Author: Ashleigh Wallace-Lacey, Pharm.D. – VISN 15/VA HCS

  Co-Author: Blake Remensnyder, Pharm.D. – VA St. Louis HCS

  Co-Author: Travis W. Linneman, Pharm.D. – VA St. Louis HCS
• 12:35 PM - 12:40 PM US PT

  Asymptomatic Bacteriuria Not a Predictor of Clinical Failure in Uncomplicated Urinary Tract Infections (uUTI): A Prospective Analysis of Women Treated for uUTI from the REASSURE Trial
  

  Rapid Fire Presenter: Steven I. Aronin, MD – Iterum Therapeutics

  Co-Author: Michael Dunne, MD – Bill & Melinda Gates Medical Research Institute

  Co-Author: Sailaja Puttagunta, MD – Iterum Therapeutics
• 12:40 PM - 12:45 PM US PT

  Dabbling with Dalbavancin: Implementation and Cost-savings of an Inpatient-to-Outpatient Dalbavancin Pathway
  

  Rapid Fire Presenter: Melissa O'Neal, PharmD (she/her/hers) – Tampa General Hospital

  Co-Author: Nicholas Piccicacco, PharmD – Tampa General Hospital

  Co-Author: Kristen Zeitler, PharmD – Tampa General Hospital

  Co-Author: Jaimie Weber, MD – Tampa General Hospital, University of South Florida Morsani College of Medicine

  Co-Author: Douglas McConnell, MD – Tampa General Hospital, University of South Florida Morsani College of Medicine

  Co-Author: Chris Conn, MSN – Tampa General Hospital

  Co-Author: Kari Carrieri, APRN – Tampa General Hospital

  Co-Author: Susannah Hall, APRN – Tampa General Hospital

  Co-Author: Jose Montero, MD – University of South Florida Morsani College of Medicine